While it is clear that in many contexts, cDC1 plays a critical role in sustaining anti‐cancer T cell responses that cannot be compensated by cDC2, the existence of non‐redundant roles for cDC2s in regulating cancer immunity remains to be determined [19, 37, 38]. The gene discussed is MPPE1; the disease is cancer.